AdaptHealth Past Earnings Performance
Past criteria checks 0/6
AdaptHealth's earnings have been declining at an average annual rate of -47.9%, while the Healthcare industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 30.4% per year.
Key information
-47.9%
Earnings growth rate
37.8%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 30.4% |
| Return on equity | -13.8% |
| Net Margin | -6.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues Are Not Doing Enough For Some Investors
Dec 10
We Think AdaptHealth (NASDAQ:AHCO) Is Taking Some Risk With Its Debt
Nov 13Returns On Capital Signal Tricky Times Ahead For AdaptHealth (NASDAQ:AHCO)
Oct 22AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Sep 06Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?
Jul 14AdaptHealth Corp.'s (NASDAQ:AHCO) Low P/S No Reason For Excitement
Jun 25AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return
Jun 04Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden
Apr 03Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost
Mar 07AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business
Feb 16Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)
Jan 18AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky
Nov 15Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture
Oct 18Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?
Sep 27Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital
Jul 19Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load
Jul 04Is Now The Time To Look At Buying AdaptHealth Corp. (NASDAQ:AHCO)?
Jun 16AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business
Apr 10Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load
Mar 22Why AdaptHealth Corp. (NASDAQ:AHCO) Could Be Worth Watching
Feb 23Investors Interested In AdaptHealth Corp.'s (NASDAQ:AHCO) Earnings
Jan 24AdaptHealth (NASDAQ:AHCO) Has A Somewhat Strained Balance Sheet
Dec 16We Ran A Stock Scan For Earnings Growth And AdaptHealth (NASDAQ:AHCO) Passed With Ease
Nov 28AdaptHealth named a Fresh Pick at Baird after investor day
Sep 19AdaptHealth: Operating Performance Stretching Up, Valuation Less So
Aug 30Revenue & Expenses Breakdown
How AdaptHealth makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3,263 | -218 | 264 | 0 |
| 30 Jun 24 | 3,261 | -690 | 260 | 0 |
| 31 Mar 24 | 3,248 | -695 | 248 | 0 |
| 31 Dec 23 | 3,200 | -679 | 241 | 0 |
| 30 Sep 23 | 3,122 | -427 | 221 | 0 |
| 30 Jun 23 | 3,075 | 42 | 214 | 0 |
| 31 Mar 23 | 3,009 | 40 | 214 | 0 |
| 31 Dec 22 | 2,971 | 63 | 210 | 0 |
| 30 Sep 22 | 2,903 | 87 | 214 | 0 |
| 30 Jun 22 | 2,800 | 125 | 212 | 0 |
| 31 Mar 22 | 2,689 | 184 | 222 | 0 |
| 31 Dec 21 | 2,465 | 142 | 236 | 0 |
| 30 Sep 21 | 2,115 | 40 | 149 | 0 |
| 30 Jun 21 | 1,746 | -64 | 125 | 0 |
| 31 Mar 21 | 1,361 | -131 | 81 | 0 |
| 31 Dec 20 | 1,071 | -162 | 68 | 0 |
| 30 Sep 20 | 858 | -91 | 79 | 0 |
| 30 Jun 20 | 710 | -44 | 67 | 0 |
| 31 Mar 20 | 602 | -50 | 58 | 0 |
| 31 Dec 19 | 530 | -21 | 39 | 0 |
| 30 Sep 19 | 489 | -8 | 42 | 0 |
| 30 Jun 19 | 454 | 8 | 37 | 0 |
| 31 Mar 19 | 398 | 14 | 32 | 0 |
| 31 Dec 18 | 345 | 23 | 24 | 0 |
| 31 Dec 17 | 193 | 10 | 12 | 0 |
| 31 Dec 16 | 174 | -4 | 11 | 0 |
Quality Earnings: AHCO is currently unprofitable.
Growing Profit Margin: AHCO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AHCO is unprofitable, and losses have increased over the past 5 years at a rate of 47.9% per year.
Accelerating Growth: Unable to compare AHCO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AHCO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).
Return on Equity
High ROE: AHCO has a negative Return on Equity (-13.79%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 03:36 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
AdaptHealth Corp. is covered by 12 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eric Coldwell | Baird |
| Kevin Fischbeck | BofA Global Research |
| Joanna Sylvia Gajuk | BofA Global Research |